CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise for rare and Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pembrolizumab (Keytruda) in 157 people with rare cancers that have spread or cannot be removed. The drug helps the immune system fight cancer by blocking a protein that tumors use to hide. The main goal is to see if the drug can stop the cancer from…
Matched conditions: CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Early trial explores cancer combo for patients with organ failure
Disease control OngoingThis early-phase study tests the safety and best dose of the drug veliparib when given with standard chemotherapy (carboplatin and paclitaxel) in adults with advanced solid tumors that also have liver or kidney dysfunction. The goal is to find out how the body processes the drugs…
Matched conditions: CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:56 UTC